New drug LAE102 put to the test in healthy women
NCT ID NCT06908707
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new drug called LAE102 in 32 healthy postmenopausal women to see if it is safe and how the body processes it. Participants received either a single dose of LAE102 or a placebo. The main goal was to check for side effects, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT FEMALE PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fortrea Clinical Trials
Daytona Beach, Florida, 32117, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does menopause change the 'Love Hormone'? a study investigates
- Gentle tai chi may soothe joint pain caused by breast cancer treatment
- Exercise eases menopause symptoms and boosts heart health in new study
- Botox for stress? tiny study tests the idea
- Exercise study reveals best way for postmenopausal women to protect their hearts
- Cancer Survivors' sex drive gets a boost: bupropion shows promise